Sonnet BioTherapeutics I...

1.23
-0.11 (-8.21%)
At close: Apr 01, 2025, 3:59 PM
1.27
2.86%
Pre-market: Apr 02, 2025, 04:34 AM EDT

Sonnet BioTherapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for SONN stock have an median target of 38, with a low estimate of 20 and a high estimate of 56. The median target predicts an increase of 2989.43% from the current stock price of 1.23.

Target Low Average Median High
Price $20 $38 $38 $56
Change 1526.02% 2989.43% 2989.43% 4452.85%

Latest Analyst Insight Report

Chardan Capital maintains a Buy rating on Sonnet B... Unlock content with Pro Subscription

Updated Dec 20, 2024

Rating May 24Aug 24Dec 24Mar 25
Strong Buy 0000
Buy 2111
Hold 0000
Sell 0000
Strong Sell 0000
Total 2 1 1 1

Financial Forecast this Year

Revenue This Year
1M
from 18.63K
Increased by 5.27K%
Revenue Next Year
6.01K
from 1M
Increased by -99.4%
EPS This Year
-3.46
from -11.35
Increased by 69.5%
EPS Next Year
-98.56
from -3.46
Increased by -2.75K%